Skip to content
healthcare.dev

XEMBIFY

NDC 13533-810, immune globulin subcutaneous, human-klhw, solution, from GRIFOLS USA, LLC.

Product NDC
13533-810
Status
Listed
Labeler
GRIFOLS USA, LLC
Dosage form
SOLUTION
Route
SUBCUTANEOUS
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125683
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/13533-810 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HUMAN IMMUNOGLOBULIN G200 mg/mL

Pharmacologic classes

Antigen Neutralization [MoA]; Human Immunoglobulin G [EPC]; Immunoglobulins [CS]; Passively Acquired Immunity [PE]

Package NDCNDC-11Package
13533-810-05135330810051 VIAL in 1 CARTON (13533-810-05) / 5 mL in 1 VIAL (13533-810-06)
13533-810-10135330810101 VIAL in 1 CARTON (13533-810-10) / 10 mL in 1 VIAL (13533-810-11)
13533-810-20135330810201 VIAL in 1 CARTON (13533-810-20) / 20 mL in 1 VIAL (13533-810-21)
13533-810-50135330810501 VIAL in 1 CARTON (13533-810-50) / 50 mL in 1 VIAL (13533-810-51)

Linked data

RxNorm, label and prices

Use it

Look up 13533-810 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/13533-810 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 13533-810. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.